Altre lingue Hexima Limited

Azioni

Mercato chiuso - Australian S.E. Altri mercati azionari 02:04:33 16/04/2024			Variaz. 5gg	Var. 1 gen.
0,012 ^AUD	+9,09%		-14,29%	-33,33%

28/02	Hexima Limited riporta i risultati degli utili per il semestre terminato il 31 dicembre 2023	CI
2023	Hexima Limited annuncia le dimissioni della Dr.ssa Nicole Van Der Weerden come Direttore	CI

Hexima Secures R&D Tax Rebate for Fiscal Year 2023	22/03
Hexima Changes Address	19/03
Hexima Limited Announces Change of Address	19/03
Hexima Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Hexima Limited Announces the Resignation of Dr. Nicole Van Der Weerden as Director	29/11
Hexima Limited Appoints Phillip Hains as A Non-Executive Director	19/09/23
Hexima Limited Appoints Geoffrey Kempler as Managing Director	06/09/23
Hexima Limited Announces Executive Changes	06/09/23
Hexima Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Hexima Limited Announces Resignation of Mr. Steven Skala as an Alternate Director	11/05/23
Hexima Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/02/23
Hexima Limited Declares Voting Results	31/01/23
Arovella Therapeutics Appoints COO	04/01/23
Hexima Acting CEO to Step Down	22/12/22
Nicole Van Der Weerden to Step Down as CEO of Hexima Limited	22/12/22
Hexima Receives AU$6 Million Tax Incentive Refund from Australian Taxation Office	14/12/22
Hexima Limited Receives Requisition Notice from Merchant Biotech Fund	14/12/22
Hexima Limited Announces Board Changes	04/12/22
10,150,000 Options of Hexima Limited are subject to a Lock-Up Agreement Ending on 1-DEC-2022.	01/12/22
6,925,878 Ordinary Shares of Hexima Limited are subject to a Lock-Up Agreement Ending on 1-DEC-2022.	01/12/22

Non ci sono risultati per questa ricerca